4.6 Article

A sustained-release Trametinib bio-multifunction hydrogel inhibits orthodontically induced inflammatory root resorption

期刊

RSC ADVANCES
卷 12, 期 26, 页码 16444-16453

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d2ra00763k

关键词

-

资金

  1. National Natural Science Foundation of China [81801005, 201870795, 21774043, 21975098, 51905526]
  2. Health Commission of Jilin Province [2018-33-05]
  3. Natural Science Foundation of Jilin Province [20200201344JC]
  4. Fundamental Research Funds for the Central Universities (JLU)
  5. Program for JLU Science and Technology Innovation Research Team [2017TD-06]

向作者/读者索取更多资源

Orthodontic tooth movement (OTM) may cause orthodontically induced inflammatory root resorption (OIIRR), which affects tooth health and treatment stability. In this study, a composite hydrogel named CCOD-Trametinib (CCOD-Tra) was developed to prevent OIIRR. The CCOD-Tra hydrogel exhibited good biocompatibility, injectability, and sustained release of Trametinib (Tra). Animal and cell experiments demonstrated that CCOD-Tra effectively prevented OIIRR by inhibiting osteoclast differentiation and maturation through the ERK1/2 signaling pathway.
Orthodontic tooth movement (OTM) is a bone reconstruction process. In most cases, OTM could induce root resorption as a common side effect, called orthodontically induced inflammatory root resorption (OIIRR). OIIRR affects tooth health and interferes with the stability of orthodontic treatment. Osteoclasts, which perform bone resorption in OTM, attack cementum, causing OIIRR. Many signaling pathways are involved in the maturation and differentiation of osteoclasts, among which the ERK1/2 is one of the important pathways. In this experiment, we added Trametinib (Tra), a specific inhibitor of ERK1/2, to catechol-modified chitosan (CHI-C) and oxidized dextran (ODex) to form a CCOD-Trametinib composite hydrogel (CCOD-Tra) to prevent OIIRR. CCOD-Tra exhibited good biocompatibility, injectability, strong adhesion, good hemostatic function and sustained release of Tra. We performed local injection of CCOD-Tra into the periodontal tissues of rats. CCOD-Tra firmly adhered to the periodontal tissues and then released Tra to establish a good biological environment and maintain a drug concentration at a high level around the roots for a long time. H&E, TRAP, immunochemistry staining and micro-CT indicated that CCOD-Tra had a good effect in terms of preventing OIIRR. Cell experiments showed that CCOD-Tra reduced the expression of TRAP, MMP-9 and C-FOS in osteoclast cells through the ERK1/2 signaling pathway to inhibit the differentiation and maturation of osteoclasts. Based on the above results, we concluded that CCOD-Tra had the ability to prevent OIIRR, the high adhesion and injectability of CCOD may provide better therapeutic ideas for clinical prevention of OIIRR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据